Clinical data | |
---|---|
Other names |
|
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.629 |
Chemical and physical data | |
Formula | C12H13N3O2 |
Molar mass | 231.255 gยทmol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Triaziquone is a drug used in chemotherapy.
It is aziridinylbenzoquinone-based, and may have potential antineoplastic activity.
It is an alkylating agent. It can react with DNA to form intrastrand crosslinks. It is a member of aziridines as well.
References
- PubChem. "Triaziquone". pubchem.ncbi.nlm.nih.gov. Retrieved 2023-10-10.
- Huang CH, Kuo HS, Liu JW, Lin YL (June 2009). "Synthesis and antitumor evaluation of novel bis-triaziquone derivatives". Molecules (Basel, Switzerland). 14 (7): 2306โ16. doi:10.3390/molecules14072306. PMC 6255275. PMID 19633605.
This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it. |